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Abstract The Xenopus laevis oocyte has endogenous sites that bind muscarinic agonists, which have been pharmacologically characterized as M3 
and/or Ml receptor subtypes. In order to define the molecular identity of the receptor protein we have analyzed a Xenopus oocyte cDNA library 
and cloned a 2.9 kb cDNA fragment encoding a muscarinic receptor (xMR). The deduced amino acid sequence reveals a protein of 484 residues 
with an apparent molecular weight of 54,188 Da. Amino acid comparison with previously cloned mammalian muscarinic receptors howed a 78% 
identity with the human m4 subtype, presenting at the same time clustered ifferences within the amino-terminal region and third intracellular loop. 
Genomic Southern analysis displayed the presence of one main gene belonging to this subtype, and the PCR analysis revealed an intronless gene. 
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1. Introduction 
The oocyte maturation process in Xenopus laevis is an impor- 
tant step in preparing this germinal cell for fertilization. The 
oocyte has two signal transducing systems regulated by G pro- 
teins that affect this process; the adenylyl cyclase (AC) and the 
phospholipase C systems (PLC) [l-6]. Progesterone inhibits the 
AC system, triggering maturation by lowering cytosolic CAMP 
levels [7-91. Acetylcholine (Ach), through an endogenous mus- 
carinic receptor, activates the PLC system, increasing intracelu- 
lar levels of inositol trisphosphate (IP3) and calcium (Ca”) 
[lo-121. 
Electrophysiological studies have shown that Ach promotes 
a complex membrane depolarization by the opening of Ca”- 
sensitive Cl- channels [6,13,14]. Similar responses have been 
found when exogenous mammalian muscarinic and SHTlc re- 
ceptors are expressed in the oocyte [l&16]. These receptors 
couple to endogenous G proteins of the GJG, subtype [ 17,181 
and activate a PLC of the /I subtype [19]. 
Pharmacological studies carried out to identify the nature of 
the endogenous receptor, led to the proposal that Xenopus 
laevis oocyte has two different muscarinic receptors in the 
plasma membrane, mainly M3 and to a lesser extent the Ml 
subtype [10,20-221; the molecular identity of this receptor, how- 
ever, remains obscure. As a first step in the understanding of 
the molecular nature and function of this G protein-coupled 
receptor, here we report the cloning, sequencing and character- 
ization of a cDNA encoding a muscarinic receptor from Xen- 
opus laevis oocyte. 
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2. Materials and methods 
2.1. Isolation and sequencing of oocyte xMR cDNA clone 
A stage VI Xenopus laevis oocyte cDNA library [23] (kindly donated 
by Dr. D. Melton, USA) was screened with an oligonucleotide corre- 
sponding to a highly conserved amino acid region present in all five 
mammalian muscarinic receptors. The primer was 5’-CTCAAGAC- 
GGTCAACAACTACTTCCTGCTGAGCCTGGCCTGCGCTGA- 
CCTCATCATCGGC3’, corresponding to the amino acid sequence 
NH,-LQTVNNYFLFSLACADLIIG-COOH. The oligonucleotide 
was labelled in its 5’ end with polynucleotide kinase and [T-~‘P]ATP, 
and probed to 300,000 independent lysis plaques. Hybridizations were 
done at 45°C in a buffer containing 1 x SSC, 5 x Denhardt’s, 10 mM 
sodium phosphate buffer, pH 6.7, 1% SDS and 100 &ml of herring 
sperm DNA. Washings were done between 45°C and 55°C in a buffer 
containing 0.1 x SSC and 0.1% SDS. One positive phage clone was 
further purified through 3 rounds of consecutive screenings and the 
cDNA subcloned into the EcoRI site of pTZl8R(+) vector (Pharma- 
cia). The DNA sequencing was performed on both strands by the 
dideoxy chain termination technique using Sequenase version 2.0 (US 
B&hem.), [a-“S]dATP and successive synthetic oligonucleotides [24]. 
2.2. PCR amplification of Xenopus genomic DNA 
PC,R amplification was carried out using Taq DNA polymerase 
(Promega Co.) under the following conditions: 30 cycles of denatura- 
tion at 94°C. 1 min; annealing at 52°C 1 mitt; and extension at 72”C, 
1 min. 
2.3. Southern blot analysis 
Genomic DNA was restriction digested, blotted onto Nytran nylon 
membranes and hybridized as described [25], with a specific “P-labeled 
probe. The DNA probe was the purified product of PCR amplification 
of a region of the xMR gene prepared using a specific pair of primers. 
3. Results 
3.1. Cloning of a cDNA encoding the complete open reading 
frame (ORF) of a Xenopus laevis oocyte muscarinic 
receptor 
Fig. 1 shows the nucleotide and amino acid deduced se- 
quence of the xMR cDNA. The cDNA sequence is 2,860 nucle- 
otides long and predicts an ORF encoding a 484 amino acid 
protein with a calculated molecular weight of 54,188 Da. The 
presence of a complete ORF in the cDNA was demonstrated 
All rights reserved. 
76 
135 
40 
dCAtCCAGCTFZAGA~XTC ??A???cCTCIT?AGCCtGGccTGCfX?GACCTT 
,~LQYVKKY ~Lr~LACAn L 
,?~TU;G1G~TK~?GC~T~~~~T~~A? AAAGGGTTACTGGCCG 
IIOVI~"KLYSLYIIKOYWP 
255 
90 
315 
100 
375 
120 
;TAA?GMCC?CC?CA?YATTAGTT ?GGAUGGTACTYCTGTGTTACCAAACCAC?GACT 
vHBLLIISLKRYYCVYKPLY 
435 
140 
'XCCAGCAAGAAGAACCACTAWAT- TMTGA?TGCRGCCGCC?GGC??C?C 495 
YPAKKTYKYAOLYIAAAKLL 160 
'CCTTTGAGCTCTGGGCCCCTGCTATTCTCTTC ?GGCAG??CAT?GTAGGACAWGGACC 
SYXLUAPAIL?UQIIVaQK? 
555 
100 
;TGCCAAGT- TGTTATATCCAGTTTCTTACCARCCCGGCAGTCACTTTTG 615 
vPSaKcYIQrL8KPAVYKaY 200 
;CCATCGCTGCCTTCTATCTTCCGGTGGTCATTATGAc?A?ACTCTACATC~?C?C? 675 
AIAAYYLPVVIYYILYI8I8 220 
:TGGCCACCRGGAGCAGAGTCCGCAGGCXTGTCCGGAAACCCG- 
LA8R8llVKRBCPlTAQKKKK 
735 
240 
XAATTAGCTCTATGAAGAGCCTTCTAATTAAGCARACAR CRACATTCCCAMCAWAC 795 
PISSYK8LLIKQYKUIYKQD 260 
XTGGAGACMGGTGGTTC GAACGGGGTGWCAATGGTGAGAAA?cA 
AODKVVKKKKOVIKOKIKK8 
es5 
280 
915 
300 
:TATCTCACMCCCTCCCTTTMGTGAGGCCTCTTCAGGGGTTGTCCTG 975 
LISKPPKKQPLIKA88QVVL 320 
;CCCCAACCCAGAGCATGCCACCACTGCCAGCARMGC RATACCGCTTCAAAGTGGTCA 
APTQSYPPLPAKAKTA8KW8 
1035 
340 
WZATCAACRTCGTCACC TGAGTGTGTGACAGCTATTCTGTT 1095 
KIKIVYKQYQKKCVYAIKIV 360 
:CAGAATGTGCCATTCCTTTGCCTGAACAGGCcMCAXAGGc CAGTCA?.CGTCGCARGA 
PKCAIPLPKQA,KAPV,VAK 
1155 
380 
~GTTT~CACCATC~CCGCRACCAGGTCAGARAAAACRCG 1215 
KPAIIAR8QVKKKKQYAAK8 400 
WZAAGGTAACCAGGACCATCTTTGCTATCCTACTGGCCTTCATCATTACCTGGACACCG 1275 
KKVYIITIPAILLAPIITIYP 420 
:5 
75 
‘0 
PACAATGTCATGGTCTTGATCMCA CCTTCTGCCAGACTTGCAYCCCA GAMCAATTTGG 1335 
YKVYVLIBYYCQYCIP8YI" 440 
~ACATTGGGTATTGGCTCTGCTATGTcAAcAGcACcATAAF,CCCAGcCTGcTATGcCCTT 1395 
YIOYULCYVB8TIKPACYAL 460 
lGCMTGCCACCTTCAAGARGACTTTCAAACA CCTCCTCATGTGTCAGTXAMAGCATT 1455 
CKAYlKKYYK8LLYCQTKSI 400 
ZGCACAGCV TAGACTTTTCTATGAGTTTGCTGACCTGTTGGCAGMG 
aTAR* 
CFGGTATTTCEAAGCCTTGAGCA TGATACGCCC-TCTTCT-TGCCCC 
kGTGCCGACAGAGGCCGG?GC CAGAGATTCCAACT AAGGAATTTGCACTAGTMTGAKT 
ZGCAGTTAGGCAGATGGGAAG TTGCAATTGTACAGTCAPIGTACCCGGGATAMGACATGT 
RCMAGTCMGACAAACTGA?TGTGTGCCACAC~T~CMG 
CACCTlWl’GGTTTACAMTTCTTCAGTCrGAGGC TCTCCGGCACXTTTTCAAATTCCGTT 
KCCAATNXCTTAGTC~~ TGAATTGAACAGTGGCU\AGTACCCCCTTCTAC 
CZTfAcArGGAGc TTTGGTTTCTT- TM-n;TTGfC?CAAC?CAC?G?G 
WXMTGGTTTA~AMTCAAC~TACGC,'CCC?AT AMGGGGTA TTT--TACATG 
CCACCCCCCTTTTTATCA~CCA~CTTCC~~TTTC~ MXAAGGCTTCAGTTCTC 
TAzGTTGTTTtGCCIGcT~- TCTGCTTTCCTATACCTGGTACAATACCC~ 
GCAICIWXGCCCXTAGCTGCAGGTTGT~TT GcAGAM?GcGcAc~rAGcucc 
ACAGCCAGVXGOXAGTAGC~~TrC~ CTAC4AXGUXGUXTCTXA 
fZZE%T ACAGAGTGCC.ATCMGX?CGGPGC~?CT~?C NXIGACTBTWWTNTGGCAGM~TC 
C lTCACAG~CTAT~2 KATCCCTT 
ATTATZETFCCWT- ~~~~CTCA~~MTATTATT 
G~A~A~A~A~A~A~~T~~~~~~~_-~~T~?M 
RTCTC~~C%T~~XCF~~~~~G 
GCAGZ~ XAGCRlTGC?CTATATAAA?AWmNX- 
t ~AG~;~(~G~~~AA~cAT~TcAcT 
-TAKGGX CTGlTG~CAGMTGCmGuIc CTGGG‘XTTT3XGA~TCC 
TTTCEMA~TTGGGTCT~CGTTGCC~MG~AC~GGAGGG 
&&CACMTATGGTAGGCTGGTTTT 
TMTGTAAPLCTT~ 
1515 
494 
Za60 
by in vitro transcription and translation of the gene, showing 
3 protein product of 54,000 Da (data not shown). The long 3’ 
tmstranslated region contains one polyadenylation signal at its 
2nd (bases 2833-2838) but no poly(A) tail was found. 
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Fig. 1. Nucleotide and deduced amino acid sequence of the Xenopus 
laevis oocyte cDNA clone. The solid bar below the amino acid sequence 
indicates the DNA region recognized by the oligonucleotide probe 
deduced from mammalian muscarinic receptor DNA sequences ml-m5 
(see section 2). The solid bar below the 3’ non-coding nucleotide region 
indicates the polyadenylation signal. Numbers at the right of the se- 
quences indicate the nucleotide and amino acid position along the 
cDNA. The single-letter amino acid code is used. 
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3.2. Analysis of the xMR predicted amino acid sequence 
All G protein-coupled receptors (GPCR) have been shown 
to possess seven hydrophobic transmembrane domains [26], 
and this feature has been used to classify our sequence as a 
GPCR, through hydropathy analysis. (data not shown). Fig. 2 
shows an alignment of the xMR protein sequence with other 
known human muscarinic species, ml-m5 [27]. The highest 
identity appears with m4 (78%), and to a lesser extent with the 
remaining sequences (between 37 and 54%). 
3.3. Structure of the xMR genomic gene by Southern and PCR 
analysis 
Xenopus genomic DNA was subjected to PCR amplification 
with 9 different oligonucleotides in order to determine the size 
of the xMR gene. Fig. 3A shows a diagram of the xMR cDNA 
and the localization of the primers utilized to amplify different 
regions of the gene. Fig. 3B shows the electrophoretic analysis 
of the PCR products. As can be seen, all PCR products corre- 
spond to the expected sizes of an intronless gene. In order to 
analyze the genomic profile of the xMR gene, a specific probe, 
described in section 2, was utilized in a Southern blot analysis. 
Xenopus genomic DNA was digested with HhaI or double di- 
gested with HhaI and PvuII. As shown in Fig. 4A the xMR 
cDNA has two HhaI sites, located at positions 247 and 2,161 
and two PvuII sites at positions 874 and 2,566. Thus in an 
intronless gene the expected hybridizing band size for the single 
digestion is 1,914 bp and two bands of 1,287 bp and 627 bp for 
the double digestion. The results shown in Fig. 4B agree with 
the restriction analysis since the DNA hybridization pattern 
obtained after the Southern blotting shows a major band close 
to 1,900 bp (HhaI single digestion) and two bands close to 1,300 
bp and 600 bp (HhaIIPvuII double digestion). From these two 
bands the one having 627 bp shows a stronger hybridization 
than the 1,287 bp fragment. The different strength in the hy- 
bridization pattern is perfectly explained by the localization of 
the probe with respect to the size of the complementary regions 
that hybridize with the probe (see Fig. 4A). 
4. Discussion 
The molecular identity of the muscarinic receptor involved 
in acetylcholine transducction signal in Xenopus oocyte is not 
yet characterized. Electrophysiological and pharmacological 
studies have implicated the M3 and Ml type receptors in this 
action. In mammalian cells these receptors are coupled to the 
phospholipase C,, increasing its activity [28]. In oocytes ace- 
tylcholine stimulates the IP3 pathway [19] or inhibit the ade- 
nylyl cyclase [32]. For a better understanding of the physiolog- 
ical role of this receptor we considered it important to charac- 
terize it at the molecular level and decided to clone its gene from 
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Fig. 2. Comparison of the deduced amino acid sequence of the Xenopus muscarinic receptor (xMR) with the five human muscarinic receptors, 
hml-hm5 [271. Identical amino acids along the sequences are indicated by * symbols and the putative transmembrane domains are indicated as I-VII 
and solid bars. 
a Xenopus laevis oocyte cDNA library. The deduced amino acid 
sequence from the cloned cDNA revealed an ORF encoding a 
protein of 458 residues (Fig. 1) with a deduced molecular weight 
of 54,188 Da The in vitro transcription and translation of the 
cloned xMR revealed a product of 54,000 Da, which is in 
agreement with the cDNA ORF. Hydrophathy analysis of the 
sequence revealed the presence of seven transmembrane do- 
mains (Fig. 2, roman numbers I-VII), indicating that the oocyte 
protein belongs to the G protein-coupled receptor family. Sur- 
prisingly, the deduced primary structure did not show the high- 
est homology with the m3 or ml subtypes (37-54%), but 
with the human m4 receptor (78%) (Fig. 2). Interestingly, the 
Xenopus receptor sequence has important amino acid differ- 
ences clustered mainly at the amino-terminal region and third 
intracellular loop. The m4 oocyte receptor could be negatively 
regulating the adenylyl cyclase activity, as it does in mammalian 
cells [28], or it could be positively regulating the phospholipase 
C activity, as previously shown by pharmacological studies 
[21,22]. Further genetic manipulation and expression of this 
gene should be done in order to clarify this issue. 
Finally at the DNA level we have established through South- 
ern analysis and PCR amplification the presence of one intron- 
less gene for a Xenopus muscarinic receptor (Figs. 3 and 4). This 
feature is shared by other muscarinic receptors [29], and consid- 
ering the strength of the major hybridizing band in comparison 
to other very faint ones (Fig. 4B) we can conclude that in 
Xenopus there is only one muscarinic receptor gene of this type 
detectable under the described hybridization conditions. 
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Fig. 3. PCR amplification of Xenopus laevis genomic DNA. (A) The 
diagram shows the Xenopus cDNA structure. The box indicates the 
open reading frame and thin black lines of the 5’ and 3’ non-coding 
regions. The arrows indicate the oligonucleotide primers used during 
the PCR amplification. The thick black bars, preceded by capital let- 
ters, indicate the amplified DNA fragments, and the numbers below the 
bars show the expected size of each fragment. (B) Electrophoretic anal- 
ysis of PCR products. Numbers at the left and at the right indicate the 
size of DNA standards. Capital letters at the top indicate the PCR 
amplified products as shown in A. 
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